Skip to main content
. 2024 Mar 7;12(3):597. doi: 10.3390/biomedicines12030597

Table 1.

Summary of gene polymorphisms which might impact CLZ treatment.

Gene Variant Genotype/Allele Predicted Phenotype Reference
DRD2 rs1800497 (Taq1A) A1/A1 or T/T
*A1 allele or T allele
Better response CLZ [18]
HTR2A rs6313 (T102C) C/C
C allele
Non-response CLZ [20,21]
HTR2A rs6314 (C1354T or His452Tyr) T/T
T allele or 452Tyr
Non-response CLZ [26,27,28]
SLC6A4 rs4795541 S/S or S allele Non-response CLZ [29]
SLC6A4 rs25531 G/G or G allele Non-response CLZ [29]
CYP1A2 rs7625521 *1F/*1F or A/A
A or *1F allele
Low CLZ plasma and non-response [33]
ABCB1 rs1045642 (C3435T) T/T or T allele High CLZ plasma and better response [34]
ABCB1 rs2032582 (G2677T) T/T or T allele High CLZ plasma and better response [34]